echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Chemicals Industry > China Chemical > PerkinElmer Introduces First Impurity Detection and Quantitation Kit for CHO HCP

    PerkinElmer Introduces First Impurity Detection and Quantitation Kit for CHO HCP

    • Last Update: 2022-04-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    PerkinElmer, Inc.
    , a global leader in innovation for a healthier world, today announced the launch of two ready-to-use HTRF® and AlphaLISA® no-wash assay kits designed to quickly and easily perform in biopharmaceutical manufacturing processes Detection and quantification of CHO HCP impurities
    .


    Recombinant therapeutic proteins, such as monoclonal antibodies, some vaccines, and other biologics, must be free of residual host cell protein (HCP) impurities that prevent the immunogenicity of the drug or reduce potency, stability, or overall effectiveness


    PerkinElmer's HTRF and AlphaLISA CHO HCP kits are the first ready-to-use homogeneous, no-wash assay kits on the market designed specifically for the detection and quantification of CHO HCP impurities
    .


    These off-the-shelf kits are designed to provide a simplified workflow, wider dynamic range, and higher sensitivity than traditional multi-step ELISA assays


    "The ability to quickly and easily detect, quantify, and subsequently eliminate CHO HCP impurities in biopharmaceutical manufacturing processes has been a key challenge," said Alan Fletcher, senior vice president of life sciences at PerkinElmer
    .


    "These innovative HTRF and AlphaLISA The test kits are designed to make this critical step more effective and efficient in existing workflows and to aid in quality control and successful biotherapeutics


    The addition of these assays further advances PerkinElmer's ability to provide scientists with end-to-end workflow solutions, from early stage drug discovery and development (including assays, cell lines, microplates and readers) to late stage R&D and High-content screening, image analysis and data management, automated liquid handling, and more


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.